GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tectonic Therapeutic Inc (NAS:TECX) » Definitions » Cash Flow from Discontinued Operations

TECX (Tectonic Therapeutic) Cash Flow from Discontinued Operations : $0.00 Mil (TTM As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Tectonic Therapeutic Cash Flow from Discontinued Operations?

Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.

Tectonic Therapeutic's cash flow from discontinued operations for the three months ended in Mar. 2025 was $0.00 Mil. It means Tectonic Therapeutic received $0.00 Mil from the sale of part of business quarterly. Tectonic Therapeutic's cash flow from discontinued operations for the trailing twelve months (TTM) ended in Mar. 2025 was $0.00 Mil.

Tectonic Therapeutic Cash Flow from Discontinued Operations Historical Data

The historical data trend for Tectonic Therapeutic's Cash Flow from Discontinued Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tectonic Therapeutic Cash Flow from Discontinued Operations Chart

Tectonic Therapeutic Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Cash Flow from Discontinued Operations
- - - -

Tectonic Therapeutic Quarterly Data
Dec21 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cash Flow from Discontinued Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Tectonic Therapeutic Cash Flow from Discontinued Operations Calculation

Cash received by a company that comes from the sale of part of business.

Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tectonic Therapeutic Cash Flow from Discontinued Operations Related Terms

Thank you for viewing the detailed overview of Tectonic Therapeutic's Cash Flow from Discontinued Operations provided by GuruFocus.com. Please click on the following links to see related term pages.

Tectonic Therapeutic Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tectonic Therapeutic Inc (NAS:TECX) » Definitions » Cash Flow from Discontinued Operations
Comparable Companies
PGEN MBX SAGE DNA SEPN AUTL MGTX ORKA NWBO ATAI VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
490 Arsenal Way, Suite 210, Watertown, MA, USA, 02472
Website
https://www.tectonictx.com
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.